Clinical trial

MagDI Italian Study

NCT06613711

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-09-20

PhaseNA

Study timeline

Study start (actual)2024-09-20Date precision: day

Registry last updated2026-05-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityverified · MONDO: obesity disorder

Type 2 Diabetes Mellitus (T2DM)unresolved

Anastomosisunresolved

Interventions

Magnet System, DI BiofragmentableDEVICE

Sponsors & collaborators

GT Metabolic Solutions, Inc.lead sponsor

Mapped research locations

MilanItaly1 NaplesItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06613711 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.